This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inga, A.
Right arrow Articles by Resnick, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inga, A.
Right arrow Articles by Resnick, M. A.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, December 2002, p. 8612-8625, Vol. 22, No. 24
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.24.8612-8625.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Differential Transactivation by the p53 Transcription Factor Is Highly Dependent on p53 Level and Promoter Target Sequence

Alberto Inga,1 Francesca Storici,1 Thomas A. Darden,2 and Michael A. Resnick1*

Laboratory of Molecular Genetics,1 Laboratory of Structural Biology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 277092

Received 24 May 2002/ Returned for modification 14 August 2002/ Accepted 10 September 2002

Little is known about the mechanisms that regulate differential transactivation by p53. We developed a system in the yeast Saccharomyces cerevisiae that addresses p53 transactivation capacity from 26 different p53 response elements (REs) under conditions where all other factors, such as chromatin, are kept constant. The system relies on a tightly regulated promoter (rheostatable) that can provide for a broad range of p53 expression. The p53 transactivation capacity toward each 20- to 22-bp-long RE could be ranked by using a simple phenotypic assay. Surprisingly, there was as much as a 1,000-fold difference in transactivation. There was no correlation between the functional rank and statistical predictions of binding energy of the REs. Instead we found that the central sequence element in an RE greatly affects p53 transactivation capacity, possibly because of DNA structural properties. Our results suggest that intrinsic DNA binding affinity and p53 protein levels are important contributors to p53-induced differential transactivation. These results are also relevant to understanding the regulation by other families of transcription factors that recognize several sequence-related response elements and/or have tightly regulated expression. We found that p53 had weak activity towards half the apoptotic REs. In addition, p53 alleles associated with familial breast cancer, previously classified as wild type, showed subtle differences in transactivation capacity towards several REs.

* Corresponding author. Mailing address: National Institute of Environmental Health Sciences (NIEHS), Mail drop D3-01, TW Alexander Dr., P.O. Box 12233, Research Triangle Park, NC 27709. Phone: (919) 541-4480. Fax: (919) 541-7593. E-mail: Resnick{at}NIEHS.NIH.GOV.

Molecular and Cellular Biology, December 2002, p. 8612-8625, Vol. 22, No. 24
0022-538X/02/$04.00+0     DOI: 10.1128/MCB.22.24.8612-8625.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Wang, B., Xiao, Z., Ren, E. C. (2009). Redefining the p53 response element. Proc. Natl. Acad. Sci. USA 106: 14373-14378 [Abstract] [Full Text]  
  • Yan, J., Menendez, D., Yang, X.-P., Resnick, M. A., Jetten, A. M. (2009). A Regulatory Loop Composed of RAP80-HDM2-p53 Provides RAP80-enhanced p53 Degradation by HDM2 in Response to DNA Damage. J. Biol. Chem. 284: 19280-19289 [Abstract] [Full Text]  
  • Chen, J., Ng, S. M., Chang, C., Zhang, Z., Bourdon, J.-C., Lane, D. P., Peng, J. (2009). p53 isoform {Delta}113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish. Genes Dev. 23: 278-290 [Abstract] [Full Text]  
  • Smeenk, L., van Heeringen, S. J., Koeppel, M., van Driel, M. A., Bartels, S. J. J., Akkers, R. C., Denissov, S., Stunnenberg, H. G., Lohrum, M. (2008). Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res 36: 3639-3654 [Abstract] [Full Text]  
  • Jegga, A. G., Inga, A., Menendez, D., Aronow, B. J., Resnick, M. A. (2008). Functional evolution of the p53 regulatory network through its target response elements. Proc. Natl. Acad. Sci. USA 105: 944-949 [Abstract] [Full Text]  
  • Cardellino, U., Ciribilli, Y., Andreotti, V., Modesto, P., Menichini, P., Fronza, G., Pellegrino, C., Inga, A. (2007). Transcriptional properties of feline p53 and its tumour-associated mutants: a yeast-based approach. Mutagenesis 22: 417-423 [Abstract] [Full Text]  
  • Tripathi, V., Ali, A., Bhat, R., Pati, U. (2007). CHIP Chaperones Wild Type p53 Tumor Suppressor Protein. J. Biol. Chem. 282: 28441-28454 [Abstract] [Full Text]  
  • Monti, P., Ciribilli, Y., Jordan, J., Menichini, P., Umbach, D. M., Resnick, M. A., Luzzatto, L., Inga, A., Fronza, G. (2007). Transcriptional Functionality of Germ Line p53 Mutants Influences Cancer Phenotype. Clin. Cancer Res. 13: 3789-3795 [Abstract] [Full Text]  
  • Ma, B., Pan, Y., Zheng, J., Levine, A. J., Nussinov, R. (2007). Sequence analysis of p53 response-elements suggests multiple binding modes of the p53 tetramer to DNA targets. Nucleic Acids Res 35: 2986-3001 [Abstract] [Full Text]  
  • Menendez, D., Inga, A., Snipe, J., Krysiak, O., Schonfelder, G., Resnick, M. A. (2007). A Single-Nucleotide Polymorphism in a Half-Binding Site Creates p53 and Estrogen Receptor Control of Vascular Endothelial Growth Factor Receptor 1. Mol. Cell. Biol. 27: 2590-2600 [Abstract] [Full Text]  
  • Lokshin, M., Li, Y., Gaiddon, C., Prives, C. (2007). p53 and p73 display common and distinct requirements for sequence specific binding to DNA. Nucleic Acids Res 35: 340-352 [Abstract] [Full Text]  
  • Barbieri, E., Mehta, P., Chen, Z., Zhang, L., Slack, A., Berg, S., Shohet, J. M. (2006). MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death.. Molecular Cancer Therapeutics 5: 2358-2365 [Abstract] [Full Text]  
  • Hamstra, D. A., Bhojani, M. S., Griffin, L. B., Laxman, B., Ross, B. D., Rehemtulla, A. (2006). Real-time Evaluation of p53 Oscillatory Behavior In vivo Using Bioluminescent Imaging.. Cancer Res. 66: 7482-7489 [Abstract] [Full Text]  
  • Landry, C. R., Wittkopp, P. J., Taubes, C. H., Ranz, J. M., Clark, A. G., Hartl, D. L. (2005). Compensatory cis-trans Evolution and the Dysregulation of Gene Expression in Interspecific Hybrids of Drosophila. Genetics 171: 1813-1822 [Abstract] [Full Text]  
  • Osada, M., Park, H. L., Nagakawa, Y., Yamashita, K., Fomenkov, A., Kim, M. S., Wu, G., Nomoto, S., Trink, B., Sidransky, D. (2005). Differential Recognition of Response Elements Determines Target Gene Specificity for p53 and p63. Mol. Cell. Biol. 25: 6077-6089 [Abstract] [Full Text]  
  • Inga, A., Reamon-Buettner, S. M., Borlak, J., Resnick, M. A. (2005). Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system. Hum Mol Genet 14: 1965-1975 [Abstract] [Full Text]  
  • Tomso, D. J., Inga, A., Menendez, D., Pittman, G. S., Campbell, M. R., Storici, F., Bell, D. A., Resnick, M. A. (2005). Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation. Proc. Natl. Acad. Sci. USA 102: 6431-6436 [Abstract] [Full Text]  
  • Ashur-Fabian, O., Avivi, A., Trakhtenbrot, L., Adamsky, K., Cohen, M., Kajakaro, G., Joel, A., Amariglio, N., Nevo, E., Rechavi, G. (2004). Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation. Proc. Natl. Acad. Sci. USA 101: 12236-12241 [Abstract] [Full Text]  
  • Demidenko, Z. N., Blagosklonny, M. V. (2004). Flavopiridol Induces p53 via Initial Inhibition of Mdm2 and p21 and, Independently of p53, Sensitizes Apoptosis-Reluctant Cells to Tumor Necrosis Factor. Cancer Res. 64: 3653-3660 [Abstract] [Full Text]  
  • Fiucci, G., Beaucourt, S., Duflaut, D., Lespagnol, A., Stumptner-Cuvelette, P., Geant, A., Buchwalter, G., Tuynder, M., Susini, L., Lassalle, J.-M., Wasylyk, C., Wasylyk, B., Oren, M., Amson, R., Telerman, A. (2004). Siah-1b is a direct transcriptional target of p53: Identification of the functional p53 responsive element in the siah-1b promoter. Proc. Natl. Acad. Sci. USA 101: 3510-3515 [Abstract] [Full Text]  
  • Reczek, E. E., Flores, E. R., Tsay, A. S., Attardi, L. D., Jacks, T. (2003). Multiple Response Elements and Differential p53 Binding Control Perp Expression During Apoptosis. Mol Cancer Res 1: 1048-1057 [Abstract] [Full Text]  
  • de Graaf, P., Little, N. A., Ramos, Y. F. M., Meulmeester, E., Letteboer, S. J. F., Jochemsen, A. G. (2003). Hdmx Protein Stability Is Regulated by the Ubiquitin Ligase Activity of Mdm2. J. Biol. Chem. 278: 38315-38324 [Abstract] [Full Text]  
  • Resnick, M. A., Inga, A. (2003). Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity. Proc. Natl. Acad. Sci. USA 100: 9934-9939 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»